Symbinas Pharmaceuticals
Manufacturing · Florida, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
450 State Road 13 N Ste 106, Saint Johns...Phone Number
(904) 716-0542Website
www.symbinas.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Symbinas Pharmaceuticals
Symbinas Pharmaceuticals Inc. is a privately held, early-stage biopharmaceutical company based in the U.S. that focuses on developing innovative therapies for Concussion and Traumatic Brain Injury (TBI). The company is dedicated to creating investigational drugs, specifically SMB-603 and SMB-710, aimed at treating the underlying cellular causes of TBI rather than just managing symptoms. With a mission to positively impact the lives of patients and families affected by TBI, Symbinas collaborates with industry leaders and experts to expedite drug development through FDA's Fast Track pathways. Their target clients include veterans, athletes, and trauma victims suffering from the long-term effects of concussions and TBI.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Symbinas Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Symbinas Pharmaceuticals recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Symbinas Pharmaceuticals is spiking on competitors!
Symbinas Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Symbinas Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Symbinas Pharmaceuticals has new funding data
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Symbinas Pharmaceuticals launches new products
Congratulate Masked Content for being promoted to Masked Content at Symbinas Pharmaceuticals
Click to see if Symbinas Pharmaceuticals had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Symbinas Pharmaceuticals
Find 3 more new buyers
Compare Similar Companies to Symbinas Pharmaceuticals
Compare insights from companies similar to Symbinas Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Symbinas Pharmaceuticals
<$5M
1-10
Private
-
-
N/A
Company Profile Activity
Activity Insights
Symbinas Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Symbinas Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Symbinas Pharmaceuticals.
Symbinas Pharmaceuticals Tech Stack
A closer look at the technologies used by Symbinas Pharmaceuticals
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Symbinas Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Symbinas Pharmaceuticals Inc. is a privately held, early-stage biopharmaceutical company based in the U.S. that focuses on developing innovative therapies for Concussion and Traumatic Brain Injury (TBI). The company is dedicated to creating investigational drugs, specifically SMB-603 and SMB-710, aimed at treating the underlying cellular causes of... Read More
